Opioid Control of Identified Midbrain GABAergic Synapses
阿片类药物对中脑 GABA 能突触的控制
基本信息
- 批准号:8266365
- 负责人:
- 金额:$ 37.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddictive BehaviorAgonistAlcoholismAnimalsBathingBehaviorBinge EatingCationsCell NucleusCellsChronicClinicalDataDevelopmentDiseaseDisinhibitionDrug AddictionElectrophysiology (science)ElementsExhibitsExposure toGlobus PallidusGrantIn VitroIndividualInhibitory SynapseInvestigationKnowledgeLabelLeadLightLimbic SystemLong-Term PotentiationMeasurementMediatingMethodsMidbrain structureModelingMorphineMotivationNeuronsNeurotransmittersNucleus AccumbensOpioidOpioid ReceptorPharmacological TreatmentPhysiologicalPlayPopulationPresynaptic ReceptorsPresynaptic TerminalsProbabilityPropertyPsychological reinforcementRattusRelative (related person)RewardsRhodopsinRoleSliceSourceStructureSynapsesSynaptic ReceptorsSynaptic plasticityTechniquesTracerVentral Tegmental AreaViralVirus DiseasesWhole-Cell Recordingsbasedesigndopaminergic neuronextracellulargamma-Aminobutyric Acidimprovedin vivomu opioid receptorsneural circuitnovelnovel strategiesoptogeneticspatch clamppostsynapticreceptorrelating to nervous systemresearch studysynaptic functiontool
项目摘要
DESCRIPTION (provided by applicant): Dopamine (DA) neurons in the midbrain ventral tegmental area (VTA) play an important role in the rewarding and reinforcing effects of opioids. Within the VTA, opioids acting at the mu opioid receptor inhibit the release of GABA, which leads to the disinhibition of DA neurons (Johnson and North, 1992a). However, GABA synapses onto VTA DA neurons arise not only from local GABAergic neurons, but also from extrinsic sources, at least some of which are likely to be sensitive to opioids. Two major external sources of inhibition onto VTA neurons arise from the nucleus accumbens (NAc) and the ventral pallidum (VP), both of which have been strongly implicated in opioid reward. These inputs have not been well defined, largely due to the technical challenge of isolating individual connections. Nevertheless, our understanding of the neural circuitry underlying opioid reward requires a thorough investigation of the synaptic properties of these VTA afferents. In this grant, we will make use of recently developed optogenetic tools to independently activate axon terminals arising from either the NAc or the VP in conjunction with whole cell patch-clamp electrophysiology from VTA neurons in midbrain slices. This will allow us to compare and contrast these two inputs and to determine how they are regulated by both acute and chronic exposure to opioids. In addition, by combining this powerful technique with retrograde labeling of VTA neurons from particular projection targets, we will be able to determine the detailed microcircuitry of these afferents within the VTA. The data provided by these studies will provide critical information for the development of circuit based models of limbic system function.
描述(由申请人提供):中脑腹侧对接区域(VTA)中的多巴胺(DA)神经元在阿片类药物的奖励和增强作用中起着重要作用。在VTA中,作用于MU阿片受体的阿片类药物抑制了GABA的释放,这导致了DA神经元的抑制作用(Johnson and North,1992a)。但是,GABA突触到VTA DA神经元上不仅来自局部GABA能神经元,而且还来自外部源,至少有些可能对阿片类药物敏感。对VTA神经元的抑制作用的两个主要外部来源来自伏隔核(NAC)和腹侧颗粒(VP),它们都与阿片类药物的奖励相关。这些输入尚未得到很好的定义,这在很大程度上是由于隔离单个连接的技术挑战。然而,我们对阿片类药物奖励基础的神经回路的理解需要彻底研究这些VTA传入的突触特性。在这笔赠款中,我们将利用最近开发的光遗传学工具来独立激活由NAC或VP引起的轴突终端,以及与中脑切片中VTA神经元的全细胞贴片钳电生理学结合使用。这将使我们能够比较和对比这两个输入,并确定如何通过急性和长期暴露于阿片类药物来调节它们。此外,通过将这种强大的技术与来自特定投影目标的VTA神经元的逆行标记相结合,我们将能够确定VTA中这些传入者的详细微电路。这些研究提供的数据将为开发基于电路的边缘系统功能的模型提供关键信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY Olaf HJELMSTAD其他文献
GREGORY Olaf HJELMSTAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY Olaf HJELMSTAD', 18)}}的其他基金
Opioid Control of Identified Midbrain GABAergic Synapses
阿片类药物对中脑 GABA 能突触的控制
- 批准号:
7948798 - 财政年份:2011
- 资助金额:
$ 37.53万 - 项目类别:
Opioid Control of Identified Midbrain GABAergic Synapses
阿片类药物对中脑 GABA 能突触的控制
- 批准号:
8445336 - 财政年份:2011
- 资助金额:
$ 37.53万 - 项目类别:
Plasticity of Kappa Opioid Function in Reward Circuitry
奖励回路中卡帕阿片类药物功能的可塑性
- 批准号:
7208055 - 财政年份:2003
- 资助金额:
$ 37.53万 - 项目类别:
Plasticity of Kappa Opioid Function in Reward Circuitry
奖励回路中卡帕阿片类药物功能的可塑性
- 批准号:
6725318 - 财政年份:2003
- 资助金额:
$ 37.53万 - 项目类别:
Plasticity of Kappa Opioid Function in Reward Circuitry
奖励回路中卡帕阿片类药物功能的可塑性
- 批准号:
6860975 - 财政年份:2003
- 资助金额:
$ 37.53万 - 项目类别:
Plasticity of Kappa Opioid Function in Reward Circuitry
奖励回路中卡帕阿片类药物功能的可塑性
- 批准号:
6556396 - 财政年份:2003
- 资助金额:
$ 37.53万 - 项目类别:
Plasticity of Kappa Opioid Function in Reward Circuitry
奖励回路中卡帕阿片类药物功能的可塑性
- 批准号:
7039153 - 财政年份:2003
- 资助金额:
$ 37.53万 - 项目类别:
NEURAL SUBSTRATES OF AVERSION DURING OPIOID WITHDRAWAL
阿片类药物戒断期间厌恶的神经基础
- 批准号:
6175799 - 财政年份:2000
- 资助金额:
$ 37.53万 - 项目类别:
NEURAL SUBSTRATES OF AVERSION DURING OPIOID WITHDRAWAL
阿片类药物戒断期间厌恶的神经基础
- 批准号:
2770072 - 财政年份:1999
- 资助金额:
$ 37.53万 - 项目类别:
相似海外基金
Prefrontal mechanisms underlying polydrug heroin and alcohol use
多种药物海洛因和酒精使用的前额叶机制
- 批准号:
10739702 - 财政年份:2023
- 资助金额:
$ 37.53万 - 项目类别:
Deciphering biased agonistic activation of mu-opioid receptor by novel optogenetic hydrogen peroxide sensor
新型光遗传学过氧化氢传感器破译μ阿片受体的偏向激动激活
- 批准号:
10604662 - 财政年份:2023
- 资助金额:
$ 37.53万 - 项目类别:
Alpha2 adrenergic receptors as a target for alcohol addiction
α2 肾上腺素能受体作为酒精成瘾的靶点
- 批准号:
10392187 - 财政年份:2022
- 资助金额:
$ 37.53万 - 项目类别:
Alpha2 adrenergic receptors as a target for alcohol addiction
α2 肾上腺素能受体作为酒精成瘾的靶点
- 批准号:
10557791 - 财政年份:2022
- 资助金额:
$ 37.53万 - 项目类别:
Pharmacological interactions between conventional and biased MOR agonists
传统 MOR 激动剂和偏向 MOR 激动剂之间的药理学相互作用
- 批准号:
10198773 - 财政年份:2020
- 资助金额:
$ 37.53万 - 项目类别: